Drug intelligence / Profile preview

Jiawei Baiyao Wan

Development stage: Unknown
Lead developer: Xizang Ganlu Tibetan Medicine and Herbal Resources Development
Modality: Small Molecules
Administration: Oral

Overview

Jiawei Baiyao Wan is a traditional Tibetan herbal medicine developed and manufactured by Xizang Ganlu Tibetan Medicine. It is an approved pharmaceutical product in China, identified by the National Drug License Number Z54020021. The formulation is a modified version of the traditional 'White Medicine' and is primarily indicated for the treatment of gastrointestinal disorders, including chronic gastritis, gastric ulcers, indigestion, and abdominal pain. According to Tibetan medical theory, it functions to harmonize the 'Peigen' humor and enhance 'digestive heat.' The medicine is composed of multiple herbal ingredients and is administered orally in a pill format.

Brand names: 加味白药丸
Other names: Jiawei Baiyao PillsModified White Medicine Pills

Beyond the preview

Go deeper on Jiawei Baiyao Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiawei Baiyao Wan.

Explore the full profile